As of March 6, 2026, no formal FDA reclassification has long been published. However, if it happens, the irony might be amazing: The grey market’s biggest vendor shuts down weeks before the compounds he invested many years selling become legally readily available by pharmacies.These drugs were initially made for diabetes but are already accepted